Image-guided focused radiation to protect thinking in brain metastases
Part of Brain & nervous system, Cancer clinical trials.
This Phase 2 trial tests a brain radiation technique that aims to treat up to a few brain metastases while sparing areas important for thinking and memory. It may help people keep cognitive abilities better than with more brain-wide radiation approaches.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You’re age 18 or older
- You have 1 to 3 brain metastases that are each under 3 cm, either still present or at a prior resection site
- Your daily function is good enough for study visits (ECOG 0–2: from fully active to limited but up to about half the day out of bed)
- You can understand the study, answer questions, and follow neurocognitive (thinking) tests
- You can have brain MRI scans with contrast, and you’re expected to live more than 6 months
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This Phase 2 trial tests a type of focused radiation (stereotactic radiosurgery, or SRS) for people with small cell lung cancer that has spread to the brain. It looks at whether this approach can treat brain metastases when the cancer has limited to a certain number of spots.
This Phase 2 study tests a quicker, more targeted way to give radiation to brain metastases. It aims to treat tumors while using regular scans to check how well the treatment controls disease and how you feel.
This trial tests a local treatment approach (focused radiation) for people with multiple brain metastases. It may help by targeting several spots in the brain while keeping treatment within certain size and safety limits.
This Phase 2 study tests a precise, no-head-frame radiation technique to treat brain metastases. It may help by aiming radiation tightly at the tumors while limiting exposure to nearby healthy brain.
This study tests a more targeted form of stereotactic (precise) brain radiation for people with brain metastases from large cell cancer. It aims to improve the balance between effectiveness and side effects by carefully focusing where the radiation goes.
This Phase 1 study tests how to safely give focused radiation (SRS) at different doses to people with brain metastases. It aims to find a dose level that works well while limiting side effects.
Hear when a new Brain Metastases, Adult trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.